Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

Kua-Uev Inhibitors

The chemical class referred to as Kua-Uev Inhibitors comprises a group of compounds meticulously designed to selectively target the molecular entity known as Kua-Uev, where Uev stands for Ubiquitin-conjugating Enzyme Variant. Kua-Uev is a member of the ubiquitin-conjugating enzyme family, which plays a crucial role in the ubiquitin-proteasome system, a fundamental cellular mechanism for protein degradation and regulation. The ubiquitin-conjugating enzymes facilitate the transfer of ubiquitin molecules to target proteins, thereby marking them for degradation or modifying their activity. While the broader ubiquitin-conjugating enzyme family is well-established, the specific functions and regulatory mechanisms associated with Kua-Uev are subjects of active investigation within the field of molecular biology. Inhibitors within the Kua-Uev Inhibitors class are intricately engineered molecules with the primary goal of modulating the activity or function of Kua-Uev, thereby inducing an inhibitory effect. Researchers in this field adopt a multifaceted approach, integrating insights from structural biology, medicinal chemistry, and computational modeling to unravel the complex molecular interactions between the inhibitors and the target Kua-Uev.

Structurally, Kua-Uev Inhibitors are characterized by specific molecular features designed to facilitate selective binding to Kua-Uev. This selectivity is crucial to minimize unintended effects on other cellular components, ensuring a focused impact on the intended molecular target. The development of inhibitors within this chemical class involves a comprehensive exploration of structure-activity relationships, optimization of pharmacokinetic properties, and a deep understanding of the molecular mechanisms associated with Kua-Uev. As researchers delve deeper into the functional aspects of Kua-Uev Inhibitors, the knowledge generated contributes not only to deciphering the specific roles of Kua-Uev but also to advancing our broader comprehension of the ubiquitin-proteasome system, cellular protein regulation, and the intricate molecular events governing protein turnover within cells. The exploration of Kua-Uev Inhibitors stands as a significant avenue for expanding fundamental knowledge in molecular biology and cell physiology.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D binds to DNA and inhibits RNA synthesis, which could reduce the occurrence of readthrough transcription events like PEDS1-UBE2V1.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

α-Amanitin inhibits RNA polymerase II, potentially decreasing the transcription of readthrough transcripts such as PEDS1-UBE2V1.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

This compound is an adenosine analog that can inhibit transcription, possibly affecting PEDS1-UBE2V1 expression.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

As an inhibitor of transcription, triptolide may potentially reduce the expression of readthrough transcripts including PEDS1-UBE2V1.

Cordycepin

73-03-0sc-203902
10 mg
$101.00
5
(1)

Cordycepin, an adenosine analog, can inhibit RNA polymerase and lead to the reduction of mRNA synthesis, possibly impacting PEDS1-UBE2V1 expression.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$259.00
41
(3)

Flavopiridol inhibits cyclin-dependent kinases and can suppress RNA polymerase II-mediated transcription, which might reduce PEDS1-UBE2V1 expression.

Rocaglamide

84573-16-0sc-203241
sc-203241A
sc-203241B
sc-203241C
sc-203241D
100 µg
1 mg
5 mg
10 mg
25 mg
$275.00
$474.00
$1639.00
$2497.00
$5344.00
4
(1)

Rocaglamide can inhibit translation and might indirectly affect the stability of readthrough transcripts like PEDS1-UBE2V1.

Harringtonin

26833-85-2sc-204771
sc-204771A
sc-204771B
sc-204771C
sc-204771D
5 mg
10 mg
25 mg
50 mg
100 mg
$250.00
$367.00
$548.00
$730.00
$980.00
30
(1)

This compound inhibits protein synthesis at the initial elongation step, which could decrease the expression of proteins from readthrough transcripts.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Cycloheximide inhibits eukaryotic protein synthesis by interfering with the translocation step in protein synthesis, which could reduce PEDS1-UBE2V1 expression.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG can modify gene expression and might have an indirect effect on the stability or expression of readthrough transcripts such as PEDS1-UBE2V1.